A citation-based method for searching scientific literature

Alexander Drilon, Lu Wang, Maria E Arcila, Sohail Balasubramanian, Joel R Greenbowe, Jeffrey S Ross, Phil Stephens, Doron Lipson, Vincent A Miller, Mark G Kris, Marc Ladanyi, Naiyer A Rizvi. Clin Cancer Res 2015
Times Cited: 150



Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa, Marileila Varella-Garcia, Woo-Ho Kim, Thomas J Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A Engelman, Lecia V Sequist, WeiWei Tan, Leena Gandhi, Mari Mino-Kenudson, Greg C Wei, S Martin Shreeve, Mark J Ratain, Jeffrey Settleman, James G Christensen, Daniel A Haber, Keith Wilner, Ravi Salgia, Geoffrey I Shapiro, Jeffrey W Clark, A John Iafrate. N Engl J Med 2010
Times Cited: 3247




List of shared articles



Times cited

Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma.
Noriko Hirai, Takaaki Sasaki, Shunsuke Okumura, Masatoshi Sado, Naoko Akiyama, Masahiro Kitada, Hidehiro Takei, Yoshinobu Ohsaki. Transl Lung Cancer Res 2020
3

An Integrated Next-Generation Sequencing System for Analyzing DNA Mutations, Gene Fusions, and RNA Expression in Lung Cancer.
Brian C Haynes, Richard A Blidner, Robyn D Cardwell, Robert Zeigler, Shobha Gokul, Julie R Thibert, Liangjing Chen, Junya Fujimoto, Vassiliki A Papadimitrakopoulou, Ignacio I Wistuba,[...]. Transl Oncol 2019
7

Pitfalls in molecular diagnostics.
Lulu Sun, John D Pfeifer. Semin Diagn Pathol 2019
3

Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC.
Alex Friedlaender, Giuseppe Banna, Sandip Patel, Alfredo Addeo. Curr Treat Options Oncol 2019
13

Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.
Mitra Mehrad, Somak Roy, Humberto Trejo Bittar, Sanja Dacic. Arch Pathol Lab Med 2018
15




Tumor biomarker testing in non-small-cell lung cancer: A decade of change.
Paul A VanderLaan, Deepa Rangachari, Adnan Majid, Mihir S Parikh, Sidharta P Gangadharan, Michael S Kent, Danielle C McDonald, Mark S Huberman, Susumu S Kobayashi, Daniel B Costa. Lung Cancer 2018
29

ALK-rearrangement in non-small-cell lung cancer (NSCLC).
Xue Du, Yun Shao, Hai-Feng Qin, Yan-Hong Tai, Hong-Jun Gao. Thorac Cancer 2018
50

Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.
Mathewos Tessema, Michael R Rossi, Maria A Picchi, Christin M Yingling, Yong Lin, Suresh S Ramalingam, Steven A Belinsky. Lung Cancer 2018
2

Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Anna Belilovski Rozenblum, Maya Ilouze, Elizabeth Dudnik, Addie Dvir, Lior Soussan-Gutman, Smadar Geva, Nir Peled. J Thorac Oncol 2017
44

Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.
Kathryn C Arbour, Gregory J Riely. Hematol Oncol Clin North Am 2017
8

Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer.
I Dagogo-Jack, A T Shaw, G J Riely. Clin Pharmacol Ther 2017
11

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
Joshua K Sabari, Fernando Santini, Isabella Bergagnini, W Victoria Lai, Kathryn C Arbour, Alexander Drilon. Curr Oncol Rep 2017
17

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives.
Giulio Rossi, Genny Jocollé, Antonia Conti, Marcello Tiseo, Federica Zito Marino, Giovanni Donati, Renato Franco, Francesca Bono, Francesca Barbisan, Francesco Facchinetti. Lung Cancer (Auckl) 2017
26